Filing Details

Accession Number:
0001214659-21-007038
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-29 17:09:26
Reporting Period:
2021-06-25
Accepted Time:
2021-06-29 17:09:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
791908 Xoma Corp XOMA Pharmaceutical Preparations (2834) 522154066
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1600865 R James Neal C/O Xoma Corporation
2200 Powell Street, Suite 310
Emeryville CA 94608
Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2021-06-25 7,170 $33.36 13,679 No 4 S Direct
Common Shares Disposition 2021-06-25 1,171 $34.30 12,508 No 4 S Direct
Common Shares Disposition 2021-06-25 686 $35.13 11,822 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
8.625% Series A Cumulative Perpetual Preferred Stock 8,000 Indirect By spouse
Depositary Shares - 8.375% B Cumulative Stock 8,000 Indirect By spouse
Common Stock 4,966 Indirect By 401(k) Plan
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.77 to $33.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.785 to $34.730, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.78 to $35.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.